Tue, August 22, 2023
Mon, August 21, 2023
Fri, August 18, 2023
Thu, August 17, 2023
Wed, August 16, 2023

Soumit Roy Initiated (ACRV) at Strong Buy and Held Target at $26 on, Aug 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-26-on-aug-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Soumit Roy of JonesTrading, Initiated "Acrivon Therapeutics, Inc." (ACRV) at Strong Buy and Held Target at $26 on, Aug 18th, 2023.

Soumit has made no other calls on ACRV in the last 4 months.



There are 3 other peers that have a rating on ACRV. Out of the 3 peers that are also analyzing ACRV, 0 agree with Soumit's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Soumit


  • Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $20 on, Friday, August 11th, 2023
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $25 on, Friday, June 2nd, 2023
  • Etzer Darout of "BMO Capital" Initiated at Buy and Held Target at $25 on, Monday, May 8th, 2023

Publication Contributing Sources